Publication | Closed Access

Salvage Treatment with Novel Agents Is Preferable to Standard Chemotherapy in Patients with Large B-Cell Lymphoma Progressing after Chimeric Antigen Receptor T-Cell Therapy

Hematological MalignancyLymphoid NeoplasiaCell TherapyHealth SciencesMedicineSalvage TreatmentStandard ChemotherapyImmunologyHematologyAutoimmunityAdult T-cell Leukemia-lymphomaImmunotherapyOncologyRadiation OncologyNovel Agents